# Safety and Efficacy of Conivaptan for the Correction of Hyponatremia in Neurological Patients

> **NCT00684164** · PHASE3 · WITHDRAWN · sponsor: **Columbia University**

## Conditions studied

- Hyponatremia

## Interventions

- **DRUG:** Conivaptan
- **OTHER:** D5

## Key facts

- **NCT ID:** NCT00684164
- **Lead sponsor:** Columbia University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-05
- **Primary completion:** 2009-11
- **Final completion:** 2010-06
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Unable to complete a contract with the Sponsor
- **Last updated:** 2015-03-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00684164

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00684164, "Safety and Efficacy of Conivaptan for the Correction of Hyponatremia in Neurological Patients". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00684164. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*